Journal of Hepatology
Volume 48, Issue 5 , Pages 697-707 , May 2008

Are HIV-infected patients candidates for liver transplantation?

  • Didier Samuel

      Affiliations

    • INSERM, U785, Villejuif F-94800, France
    • Université Paris-Sud, Faculté de Médecine, Orsay F-91400, France
    • AP-HP Hôpital Paul Brousse, Villejuif F-94800, France
    • Corresponding Author InformationCorresponding author. Address: Centre Hepato-Biliaire, Hôpital, Paul Brousse, 94800 Villejuif, France. Tel.: +33 1 45593403; fax: +33 1 45593857.
    • ,
  • Rainer Weber

      Affiliations

    • Division of Infectious Diseases, University Hospital, CH-8091 Zurich, Switzerland
    • ,
  • Peter Stock

      Affiliations

    • Department of Surgery, University of California, San Francisco, USA
    • ,
  • Jean-Charles Duclos-Vallée

      Affiliations

    • INSERM, U785, Villejuif F-94800, France
    • Université Paris-Sud, Faculté de Médecine, Orsay F-91400, France
    • AP-HP Hôpital Paul Brousse, Villejuif F-94800, France
    • ,
  • Norah Terrault

      Affiliations

    • Department of Medicine, University of California, San Francisco, USA

References 

  1. UNAIDS/WHO. AIDS epidemic update: December 2007. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS and World Health Organization, 2007.
  2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442
  3. Weber R, Sabin CA, Friis-Moller N, Reis P, El-Sadr WM, Kirk O, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Int Med. 2006;166:1632–1641
  4. Steinbrook R. One step forward, two steps back – will there ever be an AIDS vaccine?. N Engl J Med. 2007;357:2653–2655
  5. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44:S6–S9
  6. Koziel MJ, Peters MG. Viral hepatitis in HIV infection. N Engl J Med. 2007;356:1445–1454
  7. Vallet-Pichard A, Pol S. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. J Hepatol. 2006;44:S28–S34
  8. Alberti A, Clumeck N, Collins S, Gerlich W, Lundgren J, Palù G, et al. Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol. 2005;42:615–624
  9. Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis. 2005;192:992–1002
  10. Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV cohort study. Lancet. 2000;356:1800–1805
  11. den Brinker M, Wit FW, Wertheim-van Dillen PM, Juriaans S, Weel J, Van Leeuven R, et al. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection. Aids. 2000;14:2895–2902
  12. Qurishi N, Kreuzberg C, Luchters G, Lüchters G, Effenberger W, Kupfer B, et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet. 2003;362:1708–1713
  13. Zinkernagel AS, von Wyl V, Ledergerber B, Rickenbach M, Furrer H, Battegay M, et al. Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study. Antivir Ther. 2006;11:131–142
  14. Levy V, Grant RM. Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls. Clin Infect Dis. 2006;43:904–910
  15. Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA. 2000;283:74–80
  16. Nunez M. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management. J Hepatol. 2006;44:S132–S139
  17. Schenker S, Martin RR, Hoyumpa AM. Antecedent liver disease and drug toxicity. J Hepatol. 1999;31:1098–1105
  18. Mocroft A, Soriano V, Rockstroh J, Reiss P, Kirk O, De Wit S, et al. Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?. Aids. 2005;19:2117–2125
  19. Maida I, Nunez M, Rios MJ, Martin-Carbonero L, Sotgiu G, Toro C, et al. Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr. 2006;42:177–182
  20. Mallet V, Blanchard P, Verkarre V, Vallet-Pichard A, Fontaine H, Lascoux-Combe C, et al. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. Aids. 2007;21:187–192
  21. Ragni MV, Belle SH, Im K, Neff G, Roland M, Stock P, et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis. 2003;188:1412–1420
  22. Neff GW, Bonham A, Tzakis AG, Ragni M, Jayaweera D, Schiff ER, et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl. 2003;9:239–247
  23. Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation. 2003;76:370–375
  24. Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, et al. Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med. 2005;352:1317–1323
  25. Calabrese LH, Albrecht M, Young J, McCarthy P, Haug P, Jarcho J, et al. Successful cardiac transplantation in an HIV-1-infected patient with advanced disease. N Engl J Med. 2003;348:2323–2328
  26. Terrault NA, Carter JT, Carlson L, Roland ME, Stock PG. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transpl. 2006;12:801–807
  27. Duclos-Vallee JC, Feray C, Sebagh M, Teicher E, Roque-Afonso AM, Roche B, et al. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology. 2008;47:407–417
  28. Bhagat V, Foont JA, Schiff ER, Regev A. Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus. Liver Transpl. 2008;14:92
  29. Duclos-Vallée JC, Vittecoq D, Teicher E, Feray C, Roque-Afonso AM, Lombes A, et al. HCV viral recurrence and liver mitochondrial damage after liver transplantation in HIV–HCV coinfected patients. J Hepatol. 2005;42:341–349
  30. De Vera ME, Dvorchik I, Tom K, Eghtesad B, Thai N, Shakil O, et al. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transpl. 2006;6:2983–2993
  31. Pineda JA, Garcia-Garcia JA, Aguilar-Guisado M, Rios-Villegas MJ, Ruiz-Morales J, Rivero A, et al. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology. 2007;46:622–630
  32. McGovern B, Golan Y, Lopez M, Pratt D, Lawton A, Moore G, et al. The impact of cirrhosis on CD4 T cell counts in HIV-seronegative patients. Clin Infect Dis. 2007;44:431–437
  33. Benhamou Y, Di Martino V, Bochet M, Colombet C, Thibault V, Liou M, et al. Factors affecting liver fibrosis in human immunodeficiency virus-and-hepatitis C virus-coinfected patients: impact of protease inhibitor therapy. Hepatology. 2001;34:283–287
  34. Schreibman I, Gaynor JJ, Jayaweera D, Pyrsopoulos N, Weppler D, Tzakis A, et al. Outcomes after orthotopic liver transplantation in 15 HIV-infected patients. Transplantation. 2007;84:697–705
  35. Roche B, Samuel D. Risk factors for hepatitis C recurrence after liver transplantation. J Viral Hep. 2007;14:89–96
  36. Berenguer M, Royuela A, Zamora J. Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: results of a meta-analysis. Liver Transpl. 2007;13:21–29
  37. Frassetto L, Baluom M, Jacobsen W, Christians U, Roland ME, Stock PG, et al. Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients. Transplantation. 2005;80:13–17
  38. Teicher E, Vincent I, Bonhomme-Faivre L, Abbara C, Barrail A, Boissonnas A, et al. Effect of highly active antiretroviral therapy on tacrolimus pharmacokinetics in hepatitis C virus and HIV co-infected liver transplant recipients in the ANRS HC-08 study. Clin Pharmacokinet. 2007;46:941–952
  39. Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, et al. HIV-infected liver and kidney transplant recipients: 1- and 3-Year Outcomes. Am J Transplant. 2008;8:355–365
  40. Castells L, Escartin A, Bilbao I, Len O, Allende H, Vargas V, et al. Liver transplantation in HIV–HCV coinfected patients: a case-control study. Transplantation. 2007;83:354–358
  41. Ragni MV, Eghtesad B, Schlesinger KW, Dvorchik I, Fung JJ. Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl. 2005;11:1425–1430
  42. Pineda JA, Romero-Gomez M, Diaz-Garcia F, Giron-Gonzalez JA, Montero JL, Torre-Cisneros J, et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology. 2005;41:779–789
  43. Soriano V, Puoti M, Bonacini M, Brook G, Cargnel A, Rockstroh J, et al. Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV–HBV International Panel. Aids. 2005;19:221–240
  44. Norris S, Taylor C, Muiesan P, Portmann BC, Knisely AS, Bowles M, et al. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl. 2004;10:1271–1278
  45. Fung J, Eghtesad B, Patel-Tom K, DeVera M, Chapman H, Ragni M. Liver transplantation in patients with HIV infection. Liver Transpl. 2004;10:S39–S53
  46. Duclos-Vallee JC, Feray C, Sebagh M, Teicher E, Roque-Afonso AM, Roche B, et al. Liver transplantation of HIV–HCV and HIV–HBV coinfected patients:A large experience in a single centre. J Hepatol. 2006;44:S8
  47. Coffin C, Berg C, Dove L, Poordad F, Curry M, Regenstein F, et al. Survival and risk of hepatitis B virus recurrence in HIV–HBV coinfected liver transplant recipients: interim findings from the HIV–TR study. Hepatology. 2007;46:245A
  48. Wojcik K, Vogel M, Voigt E, Speidel N, Kalff JC, Goldmann G, et al. Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort. Aids. 2007;21:1363–1365
  49. Vennarecci G, Ettorre GM, Antonini M, Santoro R, Perracchio L, Visco G, et al. Liver transplantation in HIV-positive patients. Transplant Proc. 2007;39:1936–1938
  50. Castells L, Esteban JI, Bilbao I, Vargas V, Allende H, Ribera E, et al. Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients. Antivir Ther. 2006;11:1061–1070
  51. Miró J, Montejo M, Castells L, Rafecas A, Salcedo M, Fortún J, et al. Prognostic Factors of Mortality in HCV/HIV Coinfected Liver Transplant Recipients From the FIPSE OLT-HIV-05 - GESIDA 45-05 Cohort Study (2002-06). 15th CROI Meeting, Boston, MA, 2008, p. 177.
  52. Frassetto LA, Browne M, Cheng A, Wolfe AR, Roland ME, Stock PG, et al. Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Am J Transplant. 2007;7:2816–2820

☆ The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.

PII: S0168-8278(08)00128-1

doi: 10.1016/j.jhep.2008.02.009

Journal of Hepatology
Volume 48, Issue 5 , Pages 697-707 , May 2008

Article Tools